Skip to main content
SpringerLink
Log in

Small Intestine Cancer

  • Chapter
International Manual of Oncology Practice

  • 1313 Accesses

Abstract

Primary small intestine cancers are not frequent, accounting for <1 % of all adult neoplasms. Various histologic types are associated with small intestine cancer. The most common used to be adenocarcinoma; however, carcinoid tumors are showing an improved incidence and are the most common histologic type in some series. Adenocarcinomas are more frequent in the duodenum, while carcinoid tumors are more common in the ileum. Other histologic types are lymphomas and sarcomas. The symptoms are vague and non-specific. Less of an index of suspicious can cause a late the diagnosis. The stage at diagnosis is the most important prognostic factor. Radiologic and endoscopic exams can be performed to achieve a specimen sample and to stage the disease. Early tumors can be treated properly with surgical resection. Adjuvant treatment for adenocarcinoma has not been studied in large trials, but it is indicated in extrapolating colon data. The treatment for advanced adenocarcinoma of the small intestine has only been studied in a few large cohorts. Treatment for other histologic types is discussed in a separated chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics. CA Cancer J Clin 65(1):5–29

    Article  PubMed  Google Scholar 

  2. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249(1):63–71

    Article  PubMed  Google Scholar 

  3. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O et al (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8:170

    Article  PubMed Central  PubMed  Google Scholar 

  4. Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ (1993) Risk factors for small intestine cancer. Cancer Causes Control 4(2):163–169

    Article  PubMed  CAS  Google Scholar 

  5. Hatzaras I, Palesty JA, Abir F, Sullivan P, Kozol RA, Dudrick SJ et al (2007) Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. Arch Surg 142(3):229–235

    Article  PubMed  Google Scholar 

  6. Haselkorn T, Whittemore AS, Lilienfeld DE (2005) Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16(7):781–787

    Article  PubMed  Google Scholar 

  7. Wheeler JM, Warren BF, Mortensen NJ, Kim HC, Biddolph SC, Elia G et al (2002) An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50(2):218–223

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Zhang MQ, Chen ZM, Wang HL (2006) Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma. Mod Pathol 19(4):573–580

    Article  PubMed  CAS  Google Scholar 

  9. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR (2002) Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 45(11):1496–1502

    Article  PubMed  Google Scholar 

  10. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV et al (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119(6):1447–1453

    Article  PubMed  CAS  Google Scholar 

  11. Jess T, Winther KV, Munkholm P, Langholz E, Binder V (2004) Intestinal and extra-intestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen County. Denmark Aliment Pharmacol Ther 19(3):287–293

    Article  CAS  Google Scholar 

  12. Wu AH, Yu MC, Mack TM (1997) Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer 70(5):512–517

    Article  PubMed  CAS  Google Scholar 

  13. Ciresi DL, Scholten DJ (1995) The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 61(8):698–702, discussion -3

    PubMed  CAS  Google Scholar 

  14. Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the national cancer data base, 1985–1995. Cancer 86(12):2693–2706

    Article  PubMed  CAS  Google Scholar 

  15. Saha S, Hoda S, Godfrey R, Sutherland C, Raybon K (1989) Carcinoid tumors of the gastrointestinal tract: a 44-year experience. South Med J 82(12):1501–1505

    Article  PubMed  CAS  Google Scholar 

  16. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W et al (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19(18):3861–3873

    PubMed  CAS  Google Scholar 

  17. Maglinte DD, O’Connor K, Bessette J, Chernish SM, Kelvin FM (1991) The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 86(3):304–308

    PubMed  CAS  Google Scholar 

  18. Zollinger RM (1986) Primary neoplasms of the small intestine. Am J Surg 151(6):654–658

    Article  PubMed  Google Scholar 

  19. Estrin HM, Farhi DC, Ament AA, Yang P (1987) Ileoscopic diagnosis of malignant lymphoma of the small bowel in acquired immunodeficiency syndrome. Gastrointest Endosc 33(5):390–391

    Article  PubMed  CAS  Google Scholar 

  20. Lewis BS, Eisen GM, Friedman S (2005) A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 37(10):960–965

    Article  PubMed  CAS  Google Scholar 

  21. Cobrin GM, Pittman RH, Lewis BS (2006) Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer 107(1):22–27

    Article  PubMed  Google Scholar 

  22. Wiarda BM, Mensink PB, Heine DG, Stolk M, Dees J, Hazenberg H et al (2012) Small bowel Crohn’s disease: MR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy. Abdom Imaging 37(3):397–403

    Article  PubMed Central  PubMed  Google Scholar 

  23. Laurent F, Raynaud M, Biset JM, Boisserie-Lacroix M, Grelet P, Drouillard J (1991) Diagnosis and categorization of small bowel neoplasms: role of computed tomography. Gastrointest Radiol 16(2):115–119

    Article  PubMed  CAS  Google Scholar 

  24. Pilleul F, Penigaud M, Milot L, Saurin JC, Chayvialle JA, Valette PJ (2006) Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241(3):796–801

    Article  PubMed  Google Scholar 

  25. Kalady MF, Clary BM, Clark LA, Gottfried M, Rohren EM, Coleman RE et al (2002) Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol 9(8):799–806

    Article  PubMed  Google Scholar 

  26. Edge S, Byrd D, Compton C et al (eds) (2010) AJCC. Cancer staging manual, 7th edn. Springer, New York, 181 p

    Google Scholar 

  27. Frost DB, Mercado PD, Tyrell JS (1994) Small bowel cancer: a 30-year review. Ann Surg Oncol 1(4):290–295

    Article  PubMed  CAS  Google Scholar 

  28. DiSario JA, Burt RW, Vargas H, McWhorter WP (1994) Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 89(5):699–701

    PubMed  CAS  Google Scholar 

  29. Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM et al (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135(6):635–641, discussion 41-2

    Article  PubMed  CAS  Google Scholar 

  30. Singhal N, Singhal D (2007) Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev 3:CD005202

    PubMed  Google Scholar 

  31. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J (2004) Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101(3):518–526

    Article  PubMed  Google Scholar 

  32. Barnes G, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1(1):73–78

    Article  PubMed  Google Scholar 

  33. Nicholl MB, Ahuja V, Conway WC, Vu VD, Sim MS, Singh G (2010) Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol 17(10):2728–2732

    Article  PubMed  Google Scholar 

  34. Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA (2010) Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol 49(4):474–479

    Article  PubMed  Google Scholar 

  35. Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF (2010) A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg 199(6):797–803

    Article  PubMed  Google Scholar 

  36. Haan JC, Buffart TE, Eijk PP, van de Wiel MA, van Wieringen WN, Howdle PD et al (2012) Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Ann Oncol 23(2):367–374

    Article  PubMed  CAS  Google Scholar 

  37. André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27(19):3109–3116

    Article  PubMed  Google Scholar 

  38. Overman MJ, Kopetz S, Wen S, Hoff PM, Fogelman D, Morris J et al (2008) Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 113(8):2038–2045

    Article  PubMed  CAS  Google Scholar 

  39. Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS et al (2009) Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol 27(16):2598–2603

    Article  PubMed  CAS  Google Scholar 

  40. Nakayama N, Horimatsu T, Takagi S, Moriwaki T, Hirashima Y (2014) A phase II study of 5-FU/l-LV/oxaliplatin (mFOLFOX6) in patients with metastatic or unresectable small bowel adenocarcinoma. J Clin Oncol 32(suppl; abstr 3646)

    Google Scholar 

  41. Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E et al (2010) Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Ann Oncol 21(9):1786–1793

    Article  PubMed  CAS  Google Scholar 

  42. Zaanan A, Gauthier M, Malka D, Locher C, Gornet JM, Thirot-Bidault A et al (2011) Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study. Cancer 117(7):1422–1428

    Article  PubMed  CAS  Google Scholar 

  43. Sun Y, Shen P, Stewart JH, Russell GB, Levine EA (2013) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. Am Surg 79(6):644–648

    PubMed Central  PubMed  Google Scholar 

  44. Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A et al (2013) Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi64–vi72

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Federal University of São Paulo, UNIFESP, Rua Pedro de Toledo, 377, CEP 04039-031, São Paulo, SP, Brazil

    Pedro Nazareth Aguiar Jr. M.D., Carmelia Maria Noia Barreto M.D., Nora Manoukian Forones M.D., Ph.D. & Hakaru Tadokoro M.D., Ph.D.

  2. Department Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal

    Ramon Andrade de Mello M.D., Ph.D.

  3. Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal

    Ramon Andrade de Mello M.D., Ph.D.

Authors
  1. Pedro Nazareth Aguiar Jr. M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmelia Maria Noia Barreto M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nora Manoukian Forones M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hakaru Tadokoro M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ramon Andrade de Mello M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Nazareth Aguiar Jr. M.D. .

Editor information

Editors and Affiliations

  1. Medical Oncology, University of Algarve, Faro, Portugal

    Ramon Andrade de Mello

  2. edificio 7, ala nascente, 3º andar, University of Algarve, Dept Cie Biomed edificio 7, ala nascente, 3º andar, Faro, Portugal

    Álvaro Tavares

  3. Medical Oncology, University of Athens, Athens, Greece

    Giannis Mountzios

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Aguiar, P.N., Barreto, C.M.N., Forones, N.M., Tadokoro, H., de Mello, R.A. (2015). Small Intestine Cancer. In: de Mello, R., Tavares, Á., Mountzios, G. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-21683-6_15

Download citation

Publish with us

Policies and ethics

Search

Navigation